Table 3. Abdominal Pain Perceptiona.
| Pain | Control Group | Mesh Group | Effect Size, % (95% CI) | P Value |
|---|---|---|---|---|
| Presence of Abdominal Pain | ||||
| 6 wk | 26/59 (44.1) | 34/52 (65.4) | 21.3 (4 to 41) | .04b |
| 12 mo | 16/45 (35.6) | 14/40 (35.0) | 0.6 (−20 to 22) | >.99b |
| 36 mo | 7/30 (23.3) | 6/29 (20.7) | 2.6 (−20 to 25) | >.99b |
| Daily Abdominal Pain (Among Patients With Pain) | ||||
| 6 wk | 10/26 (38.5) | 17/34 (50.0) | 11.5 (−13 to 39) | .44b |
| 12 mo | 4/16 (25) | 7/14 (50) | 25 (−6 to 63) | .26b |
| 36 mo | 3/7 (42.8) | 2/6 (33.3) | 9.5 (−43 to 55) | >.99b |
| Intensity of Pain Measured With VAS Scorec (Among All Patients) | ||||
| 6 wk | 0.83 (1.61) | 1.61 (2.27) | 0.78 (0.10 to 1.46) | .02d |
| 12 mo | 0.86 (1.88) | 1.2 (2.23) | 0.34 (−0.50 to 1.17) | .42d |
| 36 mo | 0.67 (1.56) | 0.73 (2.02) | 0.07 (−0.87 to 1.00) | .89d |
Abbreviation: VAS, visual analog scale.
a
Data are presented as number per total number (percentage) of patients for presence of abdominal pain and daily abdominal pain and mean (SD) for intensity of pain.
b
Fisher exact test.
c
VAS scores from 0 to 10, with 0 indicating no pain and 10 indicating worst imaginable pain.
d
Two-tailed, unpaired t test.